272 related articles for article (PubMed ID: 17198929)
1. Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations?
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
J Ren Nutr; 2007 Jan; 17(1):30-7. PubMed ID: 17198929
[TBL] [Abstract][Full Text] [Related]
2. Possible relations between thyroid function, endothelium, and kidney and liver function in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Dec; 38(10):3509-13. PubMed ID: 17175317
[TBL] [Abstract][Full Text] [Related]
3. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
4. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
[TBL] [Abstract][Full Text] [Related]
5. Visfatin and endothelial function in dialyzed patients.
Malyszko J; Malyszko JS; Mysliwiec M
Nephrology (Carlton); 2010 Mar; 15(2):190-6. PubMed ID: 20470278
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
Małyszko J; Małyszko JS; Myśliwiec M
Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
Malyszko J; Malyszko J; Wolczynski S; Mysliwiec M
Nephrol Dial Transplant; 2006 Jan; 21(1):145-52. PubMed ID: 16141459
[TBL] [Abstract][Full Text] [Related]
8. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
Małyszko J; Małyszko JS; Myśliwiec M
Thromb Res; 2005; 115(1-2):19-24. PubMed ID: 15567448
[TBL] [Abstract][Full Text] [Related]
9. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
10. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients.
Aguilera A; Sánchez-Tomero JA; Bajo MA; Ruiz-Caravaca ML; Alvarez V; del Peso G; Herranz A; Cuesta MV; Castro MJ; Selgas R
Adv Perit Dial; 2003; 19():240-5. PubMed ID: 14763071
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Bárány P; Heimbürger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
J Intern Med; 2007 Dec; 262(6):690-701. PubMed ID: 17908160
[TBL] [Abstract][Full Text] [Related]
12. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Wolczynski S; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3466-9. PubMed ID: 19100414
[TBL] [Abstract][Full Text] [Related]
13. Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009; 41(1):150-3. PubMed ID: 19249500
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
15. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
Thromb Haemost; 2004 Mar; 91(3):480-6. PubMed ID: 14983223
[TBL] [Abstract][Full Text] [Related]
16. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
[TBL] [Abstract][Full Text] [Related]
17. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Dec; 38(10):3434-6. PubMed ID: 17175295
[TBL] [Abstract][Full Text] [Related]
18. Markers of endothelial damage in patients on hemodialysis and hemodiafiltration.
Małyszko JS; Małyszko J; Hryszko T; Koźminski P; Pawlak K; Mysliwiec M
J Nephrol; 2006; 19(2):150-4. PubMed ID: 16736412
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
[TBL] [Abstract][Full Text] [Related]
20. Structural changes in carotid arteries and impairment of fibrinolysis in hemodialyzed and peritoneally dialyzed patients.
Małyszko J; Łebkowska U; Małyszko JS; Myśliwiec M
Med Sci Monit; 2009 Dec; 15(12):CR644-9. PubMed ID: 19946236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]